I put VRTX on the Technical Trader chart pick list on September 28. The chart had a near perfect low risk setup, and it continued to look promising right up until Wednesday October 14.
Shit happens. And it happens especially with biotechs. VRTX is a biotech. When a fuxxxxxx biotech company announces after hours something about a drug trial failure, or discontinuing a promising drug, it happens.
When it happens, it becomes patently obvious that the “promising” chart pattern wasn’t promising at all.